Clinical pharmacology study of anti-parkinson's drug pramipexole

A rondomised clinical trial of the potential drug-drug interaction between pramipexole and metformin

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TTRCC-12002751

Enrollment

Unknown

Registered

2012-11-26

Start date

2012-04-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

A:Given pramipexole only

B:Given pramipexole and metformin simultaneously

Eligibility

Sex/Gender

Male

Age

19 Years to 26 Years

Inclusion criteria

Inclusion criteria: 1.Healthy male volunteers aged between 18-30. 2. One month before the trial and during the trial the volunteers should not smoking, drinking and take any other drugs.

Exclusion criteria

Exclusion criteria: 1.People who had history of disease and family medical history should exclude in this experiment; 2.People who used to drinking and smoking should exclude in this experiment.

Design outcomes

Primary

Measure	Time frame
Drug concentratio;	—

Countries

China

Contacts

Public ContactJie Liu, Huizi Wu

huizijiaguo125@gmail.com+86 0731-84805380

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026